Pieter Sonneveld, MD, PhD, discusses how the findings from the phase III CASSIOPEIA trial inform current thinking about treating patients with multiple myeloma.
Pieter Sonneveld, MD, PhD
Articles by Pieter Sonneveld, MD, PhD
Latest Updated Articles
Phase III CASSIOPEIA Impacts Treatment Decisions in Patients With Multiple MyelomaPublished: October 9th 2019 | Updated: